PIPA143053
Plasminogen Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA143053-Each-of-1 | In Stock | ₹ 20,292.00 |
PIPA143053 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 20,292.00
GST (18%): ₹ 3,652.56
Total Price: ₹ 23,944.56
Antigen
Plasminogen
Classification
Polyclonal
Conjugate
Unconjugated
Gene
PLG
Gene Alias
Ab1-346; Activation peptide; AI649309; angiostatin; DKFZp779M0222; Pg; plasmin; plasmin heavy chain A; Plasmin heavy chain A, short form; Plasmin light chain B; plasminogen; PLG; RP1-81D8.1
Host Species
Sheep
Purification Method
Ion-exchange chromatography
Regulatory Status
RUO
Gene ID (Entrez)
5340
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
ELISA, Western Blot
Concentration
15.9 mg/mL
Formulation
50% water with 50% glycerol and no preservative
Gene Accession No.
P00747
Gene Symbols
PLG
Immunogen
Human Plasminogen.
Quantity
1 mg
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- PA1-43053 detects Plasminogen in human samples
- PA1-43053 has successfully been used in Western blot and ELISA applications
- PA1-43053 was derived from human plasminogen
- Plasminogen is a plasma protein synthesized mostly in the liver
- It consists of a single polypeptide chain and has a molecular weight of 88.5 kDa
- The plasma concentration is usually in the range of 70 - 200 mg/L
- Plasminogen is activated by tissue-plasminogen activator, urokinase and streptokinase, to form plasmin
- Activation results from the cleavage and release of the preactivation peptide
- Plasmin consists of a heavy (A-) chain which contains 5 kringles and a light (B-) chain with the active site
- Plasmin is a trypsin-like protease whose natural substrate is fibrin, with binding sites for fibrin residing on the kringles
- Plasmin is essential for fibrinolysis and decreased fibrinolytic potential due to congenital defects in plasmin can lead to recurring thrombosis, thrombophlebitis and pulmonary embolism.